Standout Papers

Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes 2003 2026 2010 2018 3.4k
  1. Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes (2004)
    Christopher P. Cannon, Eugene Braunwald et al. New England Journal of Medicine
  2. Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis (2011)
    Amit Khera, Marina Cuchel et al. New England Journal of Medicine
  3. A Randomized Trial of a Low-Carbohydrate Diet for Obesity (2003)
    Gary D. Foster, Holly R. Wyatt et al. New England Journal of Medicine
  4. Assessment of Coronary Artery Disease by Cardiac Computed Tomography (2006)
    Matthew J. Budoff, Stephan Achenbach et al. Circulation
  5. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016)
    Amit V. Khera, Connor A. Emdin et al. New England Journal of Medicine
  6. New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport (2005)
    Gary F. Lewis, Daniel J. Rader Circulation Research
  7. Cholesterol Efflux and Atheroprotection (2012)
    Robert S. Rosenson, H. Bryan Brewer et al. Circulation
  8. Resistin Is an Inflammatory Marker of Atherosclerosis in Humans (2005)
    Muredach P. Reilly, Michael Lehrke et al. Circulation
  9. Electron Beam Computed Tomographic Coronary Calcium Scanning: A Review and Guidelines for Use in Asymptomatic Persons (1999)
    John A. Rumberger, Bruce H. Brundage et al. Mayo Clinic Proceedings
  10. Cholesteryl Ester Transfer Protein (2003)
    Philip J. Barter, H Bryan Brewer et al. Arteriosclerosis Thrombosis and Vascular Biology
  11. HDL and cardiovascular disease (2014)
    Daniel J. Rader, G. Kees Hovingh The Lancet
  12. Absence of Microsomal Triglyceride Transfer Protein in Individuals with Abetalipoproteinemia (1992)
    John R. Wetterau, Lawrence P. Aggerbeck et al. Science
  13. Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol (2004)
    Margaret E. Brousseau, Ernst J. Schaefer et al. New England Journal of Medicine
  14. NARC-1/PCSK9 and Its Natural Mutants (2004)
    Suzanne Benjannet, David Rhainds et al. Journal of Biological Chemistry
  15. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study (2012)
    Marina Cuchel, Emma A. Meagher et al. The Lancet
  16. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients (2011)
    Anne C. Goldberg, Paul N. Hopkins et al. Journal of clinical lipidology
  17. The Agenda for Familial Hypercholesterolemia (2015)
    Samuel S. Gidding, Mary Ann Champagne et al. Circulation
  18. Application of the tandem differential mobility analyzer to studies of droplet growth or evaporation (1986)
    Daniel J. Rader, Peter H. McMurry Journal of Aerosol Science
  19. Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing (2014)
    Qiurong Ding, Alanna Strong et al. Circulation Research
  20. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients (2011)
    Anne C. Goldberg, Paul N. Hopkins et al. Journal of clinical lipidology
  21. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study (2015)
    Danish Saleheen, Robert A. Scott et al. The Lancet Diabetes & Endocrinology
  22. Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting (2017)
    Pradeep Natarajan, Robin Young et al. Circulation
  23. NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis (2018)
    Sotirios Tsimikas, Sergio Fazio et al. Journal of the American College of Cardiology
  24. Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations (2019)
    Henry R. Kranzler, Hang Zhou et al. Nature Communications
  25. Association of Telomere Length With Risk of Disease and Mortality (2022)
    Carolin V. Schneider, Kai Markus Schneider et al. JAMA Internal Medicine

Immediate Impact

3 by Nobel laureates 16 from Science/Nature 122 standout
Sub-graph 1 of 15

Citing Papers

Polygenic scoring accuracy varies across the genetic ancestry continuum
2023 StandoutNature
Atherosclerosis: Recent developments
2022 Standout
60 intermediate papers

Works of Daniel J. Rader being referenced

A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery disease
2021
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher
2016
and 68 more

Author Peers

Author Last Decade Papers Cites
Daniel J. Rader 25601 17011 12119 13069 761 56.9k
Børge G. Nordestgaard 26288 18383 16415 7699 936 63.7k
Christie M. Ballantyne 28449 16385 19208 8370 1.1k 64.3k
John J.P. Kastelein 42487 23640 18600 9417 823 68.7k
Antonio M. Gotto 26174 16038 11477 9831 588 48.9k
Nader Rifai 20465 16018 20862 9021 450 75.0k
Joseph L. Witztum 21273 10067 10105 18095 455 70.4k
Marja‐Riitta Taskinen 16228 23571 11279 8529 565 44.3k
Wolfgang Köenig 14364 7757 11374 6826 792 45.7k
Rory Collins 18717 11641 24652 5098 243 66.2k
Frank M. Sacks 16506 14975 14944 5398 410 61.0k

All Works

Loading papers...

Rankless by CCL
2026